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Image 2:EVH 
Apparatus [6]
- EVH is a bronchoprovocation test, which stimulates exercise 
while maintaining patient CO2 levels
- Baseline spirometry followed by breathing the test gas mixture 
(5% CO2, 74% N, 21% O2) at a target minute ventilation (30 x 
FEV1) for 6 minutes
- Spirometry is then performed at 3, 5, 10, 15, and 20 minute 
time points following simulated exercise
- EVH is diagnostic if average maximum voluntary ventilation 
per minute (MVV) is >60%
- A positive test is defined as a >10% decrease in any post-EVH 
FEV1
Treatment Algorithm for EIB
- Exercise-induced bronchoconstriction (EIB), 
formerly exercise-induced asthma, has a 
prevalence of 5-20% in the general 
population and may affect up to 90% of 
patients with symptomatic asthma.
- Presents as shortness of breath, chest 
tightness, and cough 10-15 minutes after 
initiation of exercise with a 4 hour latency 
period after symptoms
- Pathophysiology thought to be related to 
dramatic increases in minute ventilation of 
large volume cool, dry air, leading to 
bronchospasm
- EIB is typically diagnosed and treated 
based on symptoms alone
- However, not all patients with these 
symptoms have EIB, and alternative 
diagnoses such as exercise-induced vocal 
cord dysfunction (EIVCD) are difficult to 
differentiate without objective testing 
- 42 yo F with no significant medical history, 
presented with dyspnea and chest 
tightness, starting 20-30 minutes into 
running exercise, resolved with rest
- Symptoms started 5 years ago
- Given an albuterol inhaler and later 
montelukast by her PCP, without 
improvement
- Referred to pulmonology and underwent 
EVH testing 
- Patients presenting with symptoms 
consistent with EIB should be considered 
for objective testing with EVH, especially if 
failing first line therapy
- EVH has been well studied in elite athletes 
and academic centers, and is being 
increasingly utilized in community settings
- EVH can also show inspiratory flow volume 
loop abnormalities, which are suggestive 
alternative conditions such as EIVCD
- EIVCD is treated with speech therapy, as 
opposed to bronchodilators for EIB
- Utilization of EVH can likely decrease 
inappropriate medication use and 
healthcare utilization and increase accuracy 
of treatment
- EVH was first used at Walter Reed Army 
Medical Center in 1985
- The results were reproducible and 
consistent on repeat EVH evaluations [7]
- A standardized protocol was created in 
2001 by Anderson et al. [6]
- EVH has been compared against exercise 
testing and methacholine challenge tests 
with similar NPV and superior PPV [2, 9]
- EVH is now considered the gold standard of 
EIB diagnosis [3]
- Patients with EIB without asthma had higher 
inflammatory mediators in sputum following 
a (+) EVH, than EVH negative patients [8]
- Multiple studies have shown a correlation 
between inspiratory flow volume loop 
flattening and vocal cord dysfunction, later 
found on VLS [4, 5]
- Test was sufficient, but 
negative for EIB (post-
EVH FEV1 <10).
- However, the inspiratory 
limb of her post-exercise 
flow volume loop was 
flattened (Image 1)
- Referred to ENT for VLS
- VLS showed paradoxical vocal cord function 
with rapid and forced breathing 
- She was diagnosed with exercise-induced 
vocal cord dysfunction (EIVCD)
- She underwent outpatient speech language 
therapy with significant improvement
Image 1: FV loop at 5 min
- EIVCD = Exercise-induced vocal cord dysfunction
- SABA = Short-acting B2 agonist
- LABA = Long-acting B2 agonist
- ICS = Inhaled corticosteroid
- LTRA = Leukotriene receptor antagonist
- Adapted and modified from the 2012 ATS guidelines 
for exercise-induced bronchoconstriction [1]
Algorithm 1: Diagnostic and 
Treatment Approach to EIB
